There were no differences between the two groups regarding pulse pressure, dyslipidemia, duration of kidney disease, or laboratory results (platelet count, Hb, total cholesterol, HDL cholesterol, and triglyceride). This evidence concerns the gene GSTM1 and kidney disorder.